93 related articles for article (PubMed ID: 8723309)
1. Association of levels of N-acetyl-beta-glucosaminidase with severity of psychiatric symptoms in panic disorder.
Garvey MJ; Noyes R
Psychiatry Res; 1996 Mar; 60(2-3):185-90. PubMed ID: 8723309
[TBL] [Abstract][Full Text] [Related]
2. An association between the lysosomal enzyme NAG and urinary free cortisol and platelet imipramine binding.
Garvey MJ; Black DW
J Psychiatr Res; 1993; 27(3):241-5. PubMed ID: 8295156
[TBL] [Abstract][Full Text] [Related]
3. Association of levels of N-acetyl-beta-glucosaminidase with specific psychiatric symptoms in bipolar patients.
Garvey MJ; Noel M
Psychiatry Res; 1993 May; 47(2):129-39. PubMed ID: 8341766
[TBL] [Abstract][Full Text] [Related]
4. An association of NAG levels and a mutation of the CCK gene in panic disorder patients.
Garvey MJ; Crowe RR; Wang Z
Psychiatry Res; 1998 Aug; 80(2):149-53. PubMed ID: 9754694
[TBL] [Abstract][Full Text] [Related]
5. NAG level differences in panic disorder and agoraphobia.
Garvey MJ; Noyes R
J Anxiety Disord; 2005; 19(7):818-25. PubMed ID: 16076427
[TBL] [Abstract][Full Text] [Related]
6. A biological difference between panic disorder and generalized anxiety disorder.
Garvey MJ; Noyes R; Woodman C; Laukes C
Biol Psychiatry; 1993 Oct; 34(8):572-5. PubMed ID: 8274587
[No Abstract] [Full Text] [Related]
7. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
[TBL] [Abstract][Full Text] [Related]
8. Association of NAG levels with specific psychiatric symptoms in unipolar patients.
Garvey MJ; Noel M
J Psychiatry Neurosci; 1995 Jan; 20(1):20-4. PubMed ID: 7865497
[TBL] [Abstract][Full Text] [Related]
9. The association of the serotonin metabolite, 5-HIAA, to the lysosomal enzyme N-acetyl-beta-glucosaminidase.
Garvey MJ; Noyes R; Woodman C; Laukes C
Neuropsychobiology; 1995; 32(2):75-8. PubMed ID: 7477804
[TBL] [Abstract][Full Text] [Related]
10. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
11. [N-acetyl-beta-D-glucosaminidase].
Furuhata N; Shiba K; Nara N
Nihon Rinsho; 1995 May; 53(5):1267-76. PubMed ID: 7602790
[TBL] [Abstract][Full Text] [Related]
12. Mood swings in patients with panic disorder.
Bowen R; South M; Hawkes J
Can J Psychiatry; 1994 Mar; 39(2):91-4. PubMed ID: 8149324
[TBL] [Abstract][Full Text] [Related]
13. Panic Disorder Severity Scale: reliability and validity of the Turkish version.
Monkul ES; Tural U; Onur E; Fidaner H; Alkin T; Shear MK
Depress Anxiety; 2004; 20(1):8-16. PubMed ID: 15368591
[TBL] [Abstract][Full Text] [Related]
14. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.
Verburg K; Griez E; Meijer J; Pols H
Am J Psychiatry; 1995 Jul; 152(7):1081-3. PubMed ID: 7793449
[TBL] [Abstract][Full Text] [Related]
15. Is carbamazepine associated with NAG elevations suggestive of renal disease?
Garvey MJ; Noel M
Brain Dev; 1995; 17(3):222-4. PubMed ID: 7573767
[TBL] [Abstract][Full Text] [Related]
16. The association between serotonin-related gene polymorphisms and panic disorder.
Yoon HK; Yang JC; Lee HJ; Kim YK
J Anxiety Disord; 2008 Dec; 22(8):1529-34. PubMed ID: 18436425
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of N-acetyl-beta glucosaminidase in upper and lower urinary tract infections in childhood. Clinical study of 168 children].
Belli A; Scalercio F; Martino F; Guido F; Aprigliano D; Lorusso G; Mannarino O; Ruberto U
Minerva Pediatr; 1996 Nov; 48(11):503-7. PubMed ID: 9064498
[TBL] [Abstract][Full Text] [Related]
18. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
[TBL] [Abstract][Full Text] [Related]
19. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
20. Significance of elevated urinary N-acetyl-beta-D-glucosaminidase activity in chronic cadmium poisoning.
Nogawa K; Yamada Y; Kido T; Honda R; Ishizaki M; Tsuritani I; Kobayashi E
Sci Total Environ; 1986 Sep; 53(3):173-8. PubMed ID: 3764409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
